AliveCor Stock
| Valuation | $943.68M1 |
| Valuation Date | Aug 16, 2022 |
| Implied Valuation | n/a |
| Last Price | $9.77 |
| 52-Week High | $9.86 |
| 52-Week Low | $9.75 |
| YTD Return | -0.81% |
| 1-Year Return | -0.81% |
| 3-Year Return | -2.30% |
| Total Funding | $284.29M2, 3 |
| Latest Round Amount | $150M1 |
| Latest Round | Series F |
| Funding Rounds | 8 |
| IPO Status | Unknown |
| Expected IPO Date | n/a |
| Revenue | n/a |
| Revenue Type | n/a |
| P/S Ratio | n/a |
About AliveCor
AliveCor is a medical device company that makes FDA-cleared personal electrocardiogram hardware and the artificial intelligence that reads it. Its KardiaMobile, KardiaMobile 6L and KardiaMobile Card devices record a medical-grade ECG in 30 seconds through a smartphone, while the Kardia 12L system is a pocket-sized, single-cable 12-lead ECG for clinicians whose KAI 12L algorithm is cleared to identify 39 cardiac determinations, including heart attack and the most common types of cardiac ischemia. AliveCor makes money by selling devices, by charging consumers for KardiaCare subscriptions that add cardiologist ECG reviews and its KardiaAlert change-detection feature, and by selling enterprise services to health systems, payers, employers and biopharma companies that need remote cardiac monitoring. It was founded by Dr. David Albert, a former chief clinical scientist of GE's cardiology division who is still its chief medical officer. AliveCor lost both of its long-running fights with Apple over Apple Watch heart monitoring: its three ECG patents were ruled unpatentable in a decision the Federal Circuit upheld in March 2025, and the Ninth Circuit affirmed the dismissal of its antitrust case in January 2026.
Invest in AliveCor
AliveCor is a private company, so you can't purchase it with a regular brokerage account. However, its shares are available on Hiive.
Hiive is a secondary marketplace where accredited investors can buy and sell shares of private, pre-IPO companies. Invest in the world's most exciting startups before they go public.
Invest on HiiveStock Analysis may be compensated for user sign-ups through Hiive links. Hiive is not affiliated with Stock Analysis. Securities offered by Hiive Markets Limited, member of FINRA/SIPC.
Related Companies
News
M-KEEPS study shows KardiaMobile 6L nearly doubles arrhythmia detection
A University of Rochester study published in JACC Advances found that 30-day KardiaMobile 6L use detected clinically significant arrhythmias in 14.9% of patients versus 7.7% with standard ambulatory m...
Diathrive Health and KardiaComplete Announce Strategic Partnership to Address Cardiometabolic Risk
Diathrive Health and AliveCor partnered to combine diabetes management with KardiaComplete virtual cardiovascular care for employer cardiometabolic programs.
Diathrive Health and KardiaComplete Announce Strategic Partnership to Address Cardiometabolic Risk
AliveCor's KardiaComplete virtual cardiovascular care service and Diathrive Health's diabetes management platform will be sold together to employers. The companies said they will align sales efforts a...
AliveCor Launches AI-Powered Kardia 12L in Europe
AliveCor received CE Mark approval for the Kardia 12L ECG system and began rollout across France, Germany, Italy, Spain, and the United Kingdom.
AliveCor Launches AI-Powered Kardia 12L in Europe: The World's First Handheld 12-Lead ECG with a Unique Single-Cable Design
AliveCor brought its handheld Kardia 12L ECG system to European markets. The launch extends a device already sold in the United States, India, Australia and New Zealand.
WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians
VANCOUVER, British Columbia--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health ou...
Ametris and AliveCor Announce Strategic Partnership to Expand Cardiac Safety Monitoring Capabilities in Clinical Research
AliveCor's medical-grade cardiac monitoring, including its FDA-cleared 6-lead ECG device, will be integrated into the Ametris digital health technology platform used in clinical trials. AliveCor also ...
AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39
AliveCor received FDA clearance for five additional KAI 12L cardiac determinations on its handheld 12-lead Kardia 12L ECG system, expanding total cleared conditions to 39.
AliveCor earns another FDA nod for AI-powered 12-lead ECG tech
The FDA cleared five new cardiac determinations for AliveCor's KAI 12L AI, adding rhythm modifiers and axis-related morphology capabilities to the Kardia 12L system.
AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39
The FDA cleared the next generation of KAI 12L, the AI behind the Kardia 12L ECG system, to detect five more cardiac determinations for a total of 39. AliveCor said the system has been adopted by more...
Apple shuts down AliveCor antitrust claims after earlier Apple Watch patent win
The Ninth Circuit affirmed summary judgment for Apple in AliveCor's antitrust case over access to Apple Watch heart rate data. The panel held that Apple's conduct was a lawful refusal to deal, ending ...
Thatch Partners with AliveCor to Offer KardiaCare Plus Through Its Marketplace
Health benefits platform Thatch will offer AliveCor's KardiaCare Plus subscription through its marketplace. The deal gives employees buying benefits through Thatch access to AliveCor's ECG devices and...
Hannover Medical School pioneers integration of GE HealthCare and AliveCor technologies to enhance cardiac care
Hannover Medical School became the first site to integrate AliveCor's ECG technology with GE HealthCare's cardiology systems. The integration routes patient-recorded ECGs into the hospital's clinical ...
AliveCor Launches First-of-its-Kind AI-Powered Kardia 12L ECG System in India
AliveCor launched the Kardia 12L ECG system in India after receiving approval from the Central Drugs Standard Control Organisation. The device detects 35 cardiac determinations, including acute myocar...
AliveCor and British Heart Foundation Join Forces in a Year-Long Campaign
AliveCor and the British Heart Foundation began a year-long campaign to raise awareness of atrial fibrillation in the United Kingdom. The partnership pairs the charity's reach with AliveCor's personal...
AliveCor Launches AI-Powered KardiaMobile 6L Max and KardiaAlert to Deliver the Most Advanced Personal ECG Solution on the Market
AliveCor launched the KardiaMobile 6L Max device bundled with a one-year KardiaCare subscription. The subscription adds KardiaAlert, which compares each ECG against a baseline recording and routes det...
Apple defeats AliveCor bid to block US smartwatch imports in US appeal
Apple convinced a U.S. appeals court on Friday to uphold its win against medical device maker AliveCor in a patent dispute that could have led to an import ban on Apple Watches.
Kardia 12L ECG System Receives CMS Reimbursement Approval
CMS included AliveCor's AI-powered ECG technology in the 2025 Hospital Outpatient Prospective Payment System final rule, setting a Medicare payment rate of $59.40 for 12-lead ECGs performed with Kardi...
New Study Shows AliveCor's Kardia 12L ECG System Performs Equivalently to a Standard 12-Lead ECG
AliveCor published study results indicating its Kardia 12L system performs equivalently to a conventional 12-lead ECG. The company uses the reduced five-electrode leadset to reconstruct a full 12-lead...
AliveCor's Services & Solutions are Now Available to Veterans
AliveCor made its cardiac monitoring devices and services available to United States veterans through the Department of Veterans Affairs. The move opens a government channel for its remote ECG product...
AliveCor's Kardia 12L ECG System Receives Category III CPT Codes
The American Medical Association granted Category III CPT codes covering the Kardia 12L ECG system. The codes let providers bill government and commercial payers for procedures using the device.
Artificial Intelligence (AI) in Medical Diagnostics Strategic Research Report 2024-2030 Featuring Agfa Healthcare, Aidoc, AliveCor, Caption Health, Elevance, HeartFlow, Intelegain, Siemens, VisualDx
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Medical Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The g...
AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System
AliveCor received two FDA clearances covering its KAI 12L artificial intelligence and the Kardia 12L hardware, launching a pocket-sized 12-lead ECG system with a single cable and five electrodes. The ...
Apple granted summary judgment in Apple Watch antitrust lawsuit brought by AliveCor
Apple Inc. AAPL, +0.86% has scored a summary judgment in an antitrust lawsuit filed by AliveCor over heart-rate technology in the Apple Watch. Federal Judge Jeffrey White of the the Northern District ...
Apple beats AliveCor lawsuit over heart-rate apps for Apple Watch
Apple persuaded a federal judge to dismiss a lawsuit by a Silicon Valley startup accusing it of illegally monopolizing the U.S. market for heart rate monitoring apps for its Apple Watch.
AliveCor Announces the ITC's Limited Exclusion Order Against Apple Clears Presidential Review
AliveCor said the International Trade Commission's limited exclusion order against Apple Watch imports cleared presidential review. The order remained stayed pending appeals over the validity of Alive...
Apple Watches violate AliveCor patents but import ban on hold -U.S. ITC
Apple Inc's Apple Watches with an electrocardiogram (ECG) function infringe patents belonging to medical device maker AliveCor Inc, the U.S. International Trade Commission affirmed on Thursday.
AliveCor Announces Series F Financing to Help Expand Offerings to Key Healthcare Industry Stakeholders
AliveCor announced a Series F financing led by GE Healthcare, with NGK-NTK joining through Pegasus Tech Ventures alongside existing investors Khosla Ventures, Bold Capital Partners, Qualcomm Ventures ...
GE Healthcare, AliveCor Partnership Aims to Increase Convenience for Patients and Help Reduce Cardiac-Related Hospitalizations by Improving the Quality and Integration of Patient Data
ORLANDO, Fla.--(BUSINESS WIRE)--Today, GE Healthcare and AliveCor announced a partnership to deliver medical-grade six-lead electrocardiograms (ECGs) taken by patients on an AliveCor KardiaMobile 6L E...
AliveCor CEO Priya Abani Named to Jacobs Board of Directors
DALLAS, Nov. 10, 2021 /PRNewswire/ -- Jacobs (NYSE:J) announced today the election of Priya Abani to its Board of Directors. With more than 20 years' experience in business and technology, Abani bring...
AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias
MOUNTAIN VIEW, Calif., July 27, 2021 /PRNewswire/ -- AliveCor, Inc. ("AliveCor"), a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services, and Acutus Medical ("Acut...
Google snaps up chief medical officer of health device maker AliveCor, weeks after buying Fitbit
Jacqueline Shreibati will join Google's health clinical team and report to chief health officer Karen DeSalvo.